Our impact

Explore how our work translates scientific breakthroughs into real-world impact. Learn more about our success stories, our commitment to sustainable laboratory practices, and access our annual reports.

Scientist in a lab, using a pipette

Our impact in numbers

13

new drugs to market

160+

new drugs into early-phase clinical trials

8 in 10

NHS cancer patients prescribed drugs linked to Cancer Research UK research

6m+

courses of treatment for cancers worldwide through drugs we helped to market

£600m+


reinvested in research from royalties and IP revenue

150+

active licences

£3bn+

raised by our start-up portfolio

79

start-ups formed

23

exits

Jonathan Kwok, co-founder of start-up Infinitopes, confidently smiling with his arms crossed

Infinitopes secures £12m seed financing

Success stories

Funding also supports the start of Phase 1/2a study for lead vaccine, ITOP1.

Read the story

Latest news

A man and a woman sat looking at a laptop

Discover how we're accelerating breakthroughs

Our annual reviews detail our research progress, commercial partnerships, start-ups and financial stewardship. We also champion responsible research through the UCL LEAF framework and report annually on our gender and ethnicity pay gap.

Read our reports

Our key portfolio areas

Three people in discussion sat at a table

Our start-up portfolio

With a growing portfolio of start-ups, we're bringing together the community to spark the next breakthrough in cancer research.

A woman sitting in front of a laptop

Licensing opportunities

Discover the innovations we have available for collaboration, that will help create the medicines of tomorrow.

Scientist with a beard using a pipette

Explore our pipeline

We've played a role in delivering 13 new cancer treatments for patients. Explore our clinical and preclinical assets currently in development.

Do you want to help bring forward the day when all cancers are conquered?

We want to hear from researchers, entrepreneurs, partners and investors.

Contact us